Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.280
-0.070 (-5.19%)
At close: Jul 7, 2025, 4:00 PM
1.250
-0.030 (-2.34%)
After-hours: Jul 7, 2025, 7:31 PM EDT
Standard BioTools Market Cap
Standard BioTools has a market cap or net worth of $486.17 million as of July 7, 2025. Its market cap has decreased by -36.27% in one year.
Market Cap
486.17M
Enterprise Value
259.64M
1-Year Change
-36.27%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since February 10, 2011, Standard BioTools's market cap has increased from $260.60M to $486.17M, an increase of 86.56%. That is a compound annual growth rate of 4.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 486.20M | -25.37% |
| Dec 31, 2024 | 651.50M | 271.23% |
| Dec 29, 2023 | 175.50M | 89.12% |
| Dec 30, 2022 | 92.80M | -69.05% |
| Dec 31, 2021 | 299.80M | -32.58% |
| Dec 31, 2020 | 444.70M | 83.68% |
| Dec 31, 2019 | 242.10M | -28.58% |
| Dec 31, 2018 | 339.00M | 48.95% |
| Dec 29, 2017 | 227.60M | 7.36% |
| Dec 30, 2016 | 212.00M | -31.88% |
| Dec 31, 2015 | 311.20M | -67.35% |
| Dec 31, 2014 | 953.00M | -2.80% |
| Dec 31, 2013 | 980.50M | 174.19% |
| Dec 31, 2012 | 357.60M | 34.23% |
| Dec 30, 2011 | 266.40M | 2.23% |
View and export this data all the way back to 2011.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |